These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
149 related items for PubMed ID: 5125064
41. [Metabolic changes in extrapyramidal syndromes and preliminary therapeutic consequences]. Bruck J, Gerstenbrand Gründig E, Prosenz P. Fortschr Neurol Psychiatr Grenzgeb; 1965 Dec; 33(12):677-91. PubMed ID: 5178727 [No Abstract] [Full Text] [Related]
42. [Amantadine treatment in parkinsonism]. Holmsen R. Tidsskr Nor Laegeforen; 1973 Oct 10; 93(28):2118-9. PubMed ID: 4773984 [No Abstract] [Full Text] [Related]
43. [Effects of amantadine therapy on sleep spindles in patients with parkinsonism and comparative analysis of L-dopa effects]. Puca FM, Pigneri MT. Boll Soc Ital Biol Sper; 1972 May 15; 48(9):237-40. PubMed ID: 5070096 [No Abstract] [Full Text] [Related]
44. I.v. amantidine sulfate for extrapyramidal crisis. Gadoth N, Sroka H, Goldhammer G, Alcalay J, Bechar M. Clin Pharm; 1985 May 15; 4(2):146. PubMed ID: 3987213 [No Abstract] [Full Text] [Related]
45. [Amantadine in the treatment of transitory hypokinesia in patients with parkinsonism during therapy with L-Dopa]. De Divitiis E, D'Andrea F, Signorelli CD, Cerillo A. Minerva Med; 1971 Oct 31; 62(82):4007-8. PubMed ID: 5125065 [No Abstract] [Full Text] [Related]
46. [Priniciples of diagnosis and treatment of patients with extrapyramidal disorders and epilepsy with the use of deep long lasting electrodes]. Ugriumov VM, Vvedenskaia IV, Grachev KV, Stepanova TS, Iatsuk SL. Vopr Neirokhir; 1967 Oct 31; 31(6):20-6. PubMed ID: 5597684 [No Abstract] [Full Text] [Related]
47. [Use of amantadine in the treatment of parkinsonism]. D'Andrea F, De Divitiis E, Signorelli CD, Cerillo A. Minerva Med; 1971 Oct 31; 62(82):3952-4. PubMed ID: 5125049 [No Abstract] [Full Text] [Related]
48. Treatment of Parkinsonism with amantadine hydrochloride. Pa Med; 1971 Apr 31; 74(4):54-5. PubMed ID: 5147644 [No Abstract] [Full Text] [Related]
49. [Amantadine in the treatment of Parkinson's disease. Results of one year]. Dalle Ore G, Bricolo A, Buffatti P, Bazzan A, Mazza C. Minerva Med; 1971 Oct 31; 62(82):3943-7. PubMed ID: 5125047 [No Abstract] [Full Text] [Related]
50. Effect of amantadine (Viregyt-K) on extrapyramidal symptoms of parkinsonian patients. Boczán G. Ther Hung; 1974 Oct 31; 22(4):147-53. PubMed ID: 4465958 [No Abstract] [Full Text] [Related]
51. [Prolonged treatment of Parkinson's disease with amantadine and L-Dopa]. Fieschi C, Casacchia M, Nardini M, Reitano N. Minerva Med; 1971 Oct 31; 62(82):4040-2. PubMed ID: 5125075 [No Abstract] [Full Text] [Related]
52. [Amantadine in the treatment of Parkinson's disease]. Giombini S, Solero CL, Bazzan A, Ferrari P, Robotti E. Fracastoro; 1970 Oct 31; 63(6):869-81. PubMed ID: 5519639 [No Abstract] [Full Text] [Related]
53. [Amantadine and L-Dopa in the treatment of parkinsonian syndromes]. Kluzer G, Lampo B. Minerva Med; 1971 Oct 31; 62(82):4013-4. PubMed ID: 5125067 [No Abstract] [Full Text] [Related]
56. [Amantadine and L-Dopa in the treatment of parkinsonian syndromes and their implications for rehabilitation]. Raspa EG, Paciaroni E, Saccomanno G. Minerva Med; 1971 Oct 31; 62(82):4031-5. PubMed ID: 5125073 [No Abstract] [Full Text] [Related]
58. [Amantadine in the therapy of Parkinson syndromes]. Pfaff G. Med Klin; 1980 Oct 24; 75(22):792-4. PubMed ID: 7453628 [No Abstract] [Full Text] [Related]